Mar 20

ON-Foundation Grants for TOBI 2020

Orthoregeneration Network Foundation (ON) and The Orthobiologic Institute (TOBI) proudly announce a collaboration to advance the field together. ON and TOBI offer ten (10) Education Grants to participate in TOBI VIRTUAL 11th Annual TOBI Orthobiologics Symposium, June 12 to 13, 2020.   Important Dates:   March 20, 2020          Online application system opens at https://my.on-foundation.org/MyEducationGrants May 12, 2020              Online application system closes June 1, 2020             ...

Mar 10

Vertebral Intraosseous Plasma Rich in Growth Factor (PRGF) Infiltrations as a Novel Strategy for the Treatment of Lumbar Pathology

TOBI Faculty, Dr. Kirchner and colleagues, have recently published their case presentation of a novel strategy for the treatment of degenerative low back pain in a recent issue of the Journal of Orthopedic Surgery and Research.  A primary motivation to adopt minimally invasive cell-based therapies in the field of Orthobiologics to treat degenerative conditions of the spine led this team of researchers and clinicians to present the first reported case description of the utilization of Vertebral Interosseous and Intervertebral disc...

Mar 10

Leukocyte-rich PRP for Knee Osteoarthritis: Current Concepts. 

Osteoarthritis is one of the most debilitating degenerative conditions affecting more than a third of the population of active individuals over the age of 65. Upon onset of clinical manifestations, osteoarthritis (OA) may become increasingly destructive regarding disease progression with respect to the microenvironment. Investigations into the leukocyte concentration in PRP formulations and its effect on the healing process in OA has created some controversy in evidence-based practice. It is well known that the inflammatory phase is integral to the...